These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9588103)

  • 21. Circadian heart rate variability in patients with primary arterial hypertension.
    Kolasińska-Kloch W; Furgała A; Banach T; Laskiewicz J; Thor PJ
    Przegl Lek; 2002; 59(9):752-5. PubMed ID: 12632903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The current status and outlook of the treatment of arterial hypertension with converting enzyme inhibitors].
    Gherasim L; Dorobanţu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(6):491-508. PubMed ID: 2908153
    [No Abstract]   [Full Text] [Related]  

  • 23. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Angioedema caused by angiotensin-converting enzyme inhibitors].
    Sojić-Rajcić J; Bogić M; Tomić-Spirić V; Rasković S
    Srp Arh Celok Lek; 2000; 128(9-10):328-30. PubMed ID: 11255687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
    Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Converting enzyme inhibitors in arterial hypertension].
    Mimran A
    Ann Cardiol Angeiol (Paris); 1991 Jun; 40(6):351-7. PubMed ID: 1859141
    [No Abstract]   [Full Text] [Related]  

  • 27. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme inhibitors and cough--a north Indian study.
    Singh NP; Uppal M; Anuradha S; Agarwal A; Rizvi SN
    J Assoc Physicians India; 1998 May; 46(5):448-51. PubMed ID: 11273288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases.
    Lefebvre HP; Toutain PL
    J Vet Pharmacol Ther; 2004 Oct; 27(5):265-81. PubMed ID: 15500563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system.
    de la Sierra A
    J Hum Hypertens; 2009 Aug; 23(8):503-11. PubMed ID: 19148104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D
    Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials.
    Bertrand ME
    Curr Med Res Opin; 2004 Oct; 20(10):1559-69. PubMed ID: 15462689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension].
    Krezsinski JM; Sternon J
    Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Angiotensin converting enzyme inhibitors. Increasing importance in the treatment of hypertension].
    Januszewicz A; Lapiński M
    Kardiol Pol; 1992 Dec; 37(12):393-7. PubMed ID: 1293350
    [No Abstract]   [Full Text] [Related]  

  • 39. [Angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension].
    Horký K
    Vnitr Lek; 1996 Feb; 42(2):110-3. PubMed ID: 8686183
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.